Respiratory virus vaccine effectiveness and safety for influenza, RSV, and COVID-19 are reviewed, including new evidence, risks, and recommendations. JAMA Deputy Editor Preeti Malani, MD, MSJ, speaks with Rochelle Walensky, MD, MPH, professor of medicine at Harvard Medical School and former CDC Director, about vaccine data, public trust, and the 2026 respiratory virus season.
Podden och tillhörande omslagsbild på den här sidan tillhör
JAMA Network. Innehållet i podden är skapat av JAMA Network och inte av,
eller tillsammans med, Poddtoppen.
